Additionally, injecting NK cells restores NK cytotoxicity and enhances IFN-γ secretion in various immune cell populations, including PBMCs, splenocytes, bone marrow-derived cells, enriched NK cells, and purified T cells, in tumor-bearing humanized mice [56,58,59]. The gene discussed is IFNG; the disease is neoplasm.